REDucing Hot FLASHes in Women Using Endocrine Therapy.

NCT06106529 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Hot Flash Due to Medication

Interventions

DRUG: Oxybutynin
DRUG: Venlafaxine

Sponsor

Reinier de Graaf Groep